MoneyWorks4Me

The revenue slipped marginally during the December 2025 quarter. A decline of about Rs. 729.45 millions was observed as compared to Rs. 740.25 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 109.51 millions from Rs. 319.90 millions, a decline of -65.77% on QoQ basis.Operating profit surged to 192.43 millions from the corresponding previous quarter of 181.56 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 729.45 740.25 -1.46 2230.22 2101.56 6.12 2687.16 2087.02 28.76
Other Income 29.75 23.22 28.12 88.27 54.20 62.86 81.90 92.79 -11.74
PBIDT 192.43 181.56 5.99 557.42 477.77 16.67 592.61 323.46 83.21
Interest 2.57 2.55 0.78 7.76 6.99 11.02 9.58 8.14 17.69
PBDT 169.07 410.85 -58.85 528.87 669.77 -21.04 779.90 315.32 147.34
Depreciation 23.86 24.13 -1.12 71.25 58.26 22.30 81.31 16.63 388.94
PBT 145.21 386.72 -62.45 457.62 611.51 -25.17 698.59 298.69 133.88
TAX 35.70 66.82 -46.57 114.42 123.73 -7.52 144.98 74.06 95.76
Deferred Tax -1.79 -13.80 -87.03 7.15 0.40 1687.50 9.26 -1.54 -701.30
PAT 109.51 319.90 -65.77 343.20 487.78 -29.64 553.61 224.63 146.45
Equity 133.57 132.29 0.97 133.57 132.42 0.87 132.80 132.19 0.46
PBIDTM(%) 26.38 24.53 7.56 24.99 22.73 9.94 22.05 15.50 42.29
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..